<?xml version="1.0" ?>
<rss version="2.0">
<channel>
<title>CLINICAL RESEARCH &amp; DIAGNOSTICS Clinical Trials Update news from GEN</title><description>Latest news on the progress of drug candidates through the different phases of clinical trials.</description>
<lastBuildDate>Saturday, November 21, 2009</lastBuildDate><link>http://www.genengnews.com/news/newslist.aspx?taxid=26</link>
<item>
<title>POZEN Announces Start of Enrollment For PA32540 Phase 3 Program</title>
<description></description>
<pubDate>Friday, November 20, 2009</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=69035467</link>
</item>
<item>
<title>Novavax Prices Public Offering of Common Stock</title>
<description></description>
<pubDate>Friday, November 20, 2009</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=69039441</link>
</item>
<item>
<title>Stem Cell Therapeutics Corp. Announces Positive Review by Data Safety
 and Monitoring Board for the Phase IIb Stroke Trial</title>
<description></description>
<pubDate>Friday, November 20, 2009</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=69036280</link>
</item>
<item>
<title>The New Face of Formatech.com</title>
<description></description>
<pubDate>Friday, November 20, 2009</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=69022437</link>
</item>
</channel>
</rss>
